Market Cap 819.46M
Revenue (ttm) 403.14M
Net Income (ttm) -22.68M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -5.63%
Debt to Equity Ratio -0.50
Volume 59,090,402
Avg Vol 17,213,020
Day's Range N/A - N/A
Shares Out 257.69M
Stochastic %K 75%
Beta 1.07
Analysts Hold
Price Target $2.97

Company Profile

Esperion Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia cardiovascular disease who...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 734 887 3903
Address:
3891 Ranchero Drive, Suite 150, Ann Arbor, United States
Enjoyycall
Enjoyycall Aug. 21 at 9:23 PM
$PSNL has already reached the same pre-close takeout-pump zone we saw in other M&A targets (including $ESPR in the 6–12 months before its deal). If I’m right, it drifts back down and settles in the 16.xx area (anchored to the $16.25 takeout). Should the close slip past January 1st, year-end emotions + tax-loss selling will add extra pressure — exactly the kind of setup they would aim for. Right now, it’s trading at roughly 1.15% of the take-out price, the same late-stage relationship we saw in ESPR (+CVR) and other M&A names just prior to closing
1 · Reply
maxhappy
maxhappy Aug. 21 at 5:12 PM
$ESPR Nobody asking for weekly scripts? I'm still here and I will forever think that Sheldung Koenig is one of the worst biotech CEOs of all time. He is a proud member:
0 · Reply
Enjoyycall
Enjoyycall Aug. 20 at 10:19 PM
$ESPR Knock knock DJ its coming....TDS will OWN YOU !
1 · Reply
__LucidDreamer__
__LucidDreamer__ Aug. 20 at 4:21 PM
$ESPR saw rumor that Sheldon allowed the execs at Daiichi and Otsuka to regularly fist him during late night "negotiations". Sheldon wasn't really open to it, until Ben explained that, since they were Asian, they had smaller hands. #probablytrue
1 · Reply
Enjoyycall
Enjoyycall Aug. 20 at 4:07 PM
$ESPRWe are squeezing the dog crap out of you fake bulls!!! Too bad most deleted and ran or blocked when ironically they cried about being blocked by others, we are still banking, the foot is and has been on! Furus all exposed, no inside info no nothing! The way it should be, skill only. Go mow the yard lol
0 · Reply
HowDidThatGetInThere
HowDidThatGetInThere Aug. 18 at 4:16 PM
$ESPR Wonder how much Sheldon made on this aquisition.
0 · Reply
Enjoyycall
Enjoyycall Aug. 18 at 2:19 PM
$ESPR GUTS lol still not there. Many thought they would, but almost all can't. Back to your cube lol
0 · Reply
Enjoyycall
Enjoyycall Aug. 18 at 12:24 AM
$ESPR Hows the cube working. Post more pictures...Why no derogatory words about the C suite. Come find me, I'll send the address
1 · Reply
Enjoyycall
Enjoyycall Aug. 12 at 5:52 AM
$ESPR Wonder what DJ looks like…will he be crying in the photo
1 · Reply
Enjoyycall
Enjoyycall Aug. 12 at 1:12 AM
$ESPR Even more accounts deleted. X accounts nuked too, some abandoned from our request. Run, but can’t hide
0 · Reply
Latest News on ESPR
Esperion Therapeutics Transcript: EGM 2026

Jul 8, 2026, 8:00 AM EDT - 6 weeks ago

Esperion Therapeutics Transcript: EGM 2026


Esperion Therapeutics Proxy statement: Proxy filing

Jun 16, 2026, 8:00 AM EDT - 2 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Proxy statement: Proxy filing

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Proxy statement: Proxy filing

May 29, 2026, 8:00 AM EDT - 3 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Transcript: AGM 2026

May 28, 2026, 8:00 AM EDT - 3 months ago

Esperion Therapeutics Transcript: AGM 2026


Esperion Therapeutics Quarterly report: Q1 2026

May 8, 2026, 7:00 AM EDT - 3 months ago

Esperion Therapeutics Quarterly report: Q1 2026


Esperion Therapeutics Proxy statement: Proxy filing

May 4, 2026, 8:00 AM EDT - 4 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Proxy statement: Proxy filing

May 1, 2026, 8:00 AM EDT - 4 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Proxy statement: Proxy filing

May 1, 2026, 8:00 AM EDT - 4 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion to be Acquired by ARCHIMED

May 1, 2026, 7:00 AM EDT - 4 months ago

Esperion to be Acquired by ARCHIMED

ESPR


Esperion Therapeutics Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 4 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 4 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Earnings Call Transcript: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 6 months ago

Esperion Therapeutics Earnings Call Transcript: Q4 2025


Esperion Therapeutics Annual report: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 6 months ago

Esperion Therapeutics Annual report: Q4 2025


Esperion Therapeutics Earnings release: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 6 months ago

Esperion Therapeutics Earnings release: Q4 2025


Esperion Therapeutics Slides: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 6 months ago

Esperion Therapeutics Slides: Q4 2025


Esperion Therapeutics Slides: Corporate presentation

Mar 9, 2026, 7:00 AM EDT - 6 months ago

Esperion Therapeutics Slides: Corporate presentation


Esperion Therapeutics Transcript: M&A announcement

Mar 3, 2026, 8:00 AM EST - 6 months ago

Esperion Therapeutics Transcript: M&A announcement


Esperion Therapeutics Press release: M&A announcement

Mar 3, 2026, 8:00 AM EST - 6 months ago

Esperion Therapeutics Press release: M&A announcement


Esperion Therapeutics Slides: M&A announcement

Mar 3, 2026, 8:00 AM EST - 6 months ago

Esperion Therapeutics Slides: M&A announcement


Esperion Therapeutics Transcript: KOL Event

Nov 11, 2025, 2:00 PM EST - 10 months ago

Esperion Therapeutics Transcript: KOL Event


Esperion Therapeutics Slides: KOL Event

Nov 11, 2025, 2:00 PM EST - 10 months ago

Esperion Therapeutics Slides: KOL Event


Esperion Therapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Esperion Therapeutics Earnings Call Transcript: Q3 2025


Esperion Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Esperion Therapeutics Quarterly report: Q3 2025


Esperion Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Esperion Therapeutics Earnings release: Q3 2025


Esperion Therapeutics Slides: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Esperion Therapeutics Slides: Q3 2025


Esperion Announces Pricing of Public Offering of Common Stock

Oct 7, 2025, 9:29 PM EDT - 11 months ago

Esperion Announces Pricing of Public Offering of Common Stock

ESPR


Esperion Announces Proposed Public Offering of Common Stock

Oct 7, 2025, 4:01 PM EDT - 11 months ago

Esperion Announces Proposed Public Offering of Common Stock

ESPR


Esperion Therapeutics Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Earnings Call Transcript: Q2 2025


Esperion Therapeutics Quarterly report: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Quarterly report: Q2 2025


Esperion Therapeutics Earnings release: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Earnings release: Q2 2025


Esperion Therapeutics Slides: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Slides: Q2 2025


Esperion Appoints Craig Thompson to Board of Directors

Jul 1, 2025, 8:06 AM EDT - 1 year ago

Esperion Appoints Craig Thompson to Board of Directors

ESPR


Esperion Therapeutics Earnings Call Transcript: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Earnings Call Transcript: Q1 2025


Esperion Therapeutics Quarterly report: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Quarterly report: Q1 2025


Esperion Therapeutics Earnings release: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Earnings release: Q1 2025


Esperion Therapeutics Slides: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Slides: Q1 2025


Esperion Therapeutics Transcript: Status Update

Apr 24, 2025, 9:00 AM EDT - 1 year ago

Esperion Therapeutics Transcript: Status Update


Esperion Therapeutics Press release: Status Update

Apr 24, 2025, 9:00 AM EDT - 1 year ago

Esperion Therapeutics Press release: Status Update


Esperion Therapeutics Slides: Status Update

Apr 24, 2025, 9:00 AM EDT - 1 year ago

Esperion Therapeutics Slides: Status Update


Esperion Therapeutics Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Proxy statement: Proxy Filing


Esperion Therapeutics Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Proxy statement: Proxy Filing


Esperion Appoints Robert E. Hoffman to Board of Directors

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Esperion Appoints Robert E. Hoffman to Board of Directors

ESPR


Esperion Therapeutics Earnings Call Transcript: Q4 2024

Mar 4, 2025, 8:00 AM EST - 1 year ago

Esperion Therapeutics Earnings Call Transcript: Q4 2024


Esperion Therapeutics Annual report: Q4 2024

Mar 4, 2025, 8:00 AM EST - 1 year ago

Esperion Therapeutics Annual report: Q4 2024


Esperion Therapeutics Earnings release: Q4 2024

Mar 4, 2025, 8:00 AM EST - 1 year ago

Esperion Therapeutics Earnings release: Q4 2024


Esperion Therapeutics Slides: Q4 2024

Mar 4, 2025, 8:00 AM EST - 1 year ago

Esperion Therapeutics Slides: Q4 2024


Esperion Therapeutics Transcript: KOL Event

Jan 22, 2025, 12:30 PM EST - 1 year ago

Esperion Therapeutics Transcript: KOL Event


Esperion Therapeutics Slides: KOL Event

Jan 22, 2025, 12:30 PM EST - 1 year ago

Esperion Therapeutics Slides: KOL Event


Esperion Therapeutics Slides: FY 2025

Jan 15, 2025, 6:45 PM EST - 1 year ago

Esperion Therapeutics Slides: FY 2025


Esperion Announces $210 Million Convertible Debt Financing

Dec 13, 2024, 6:00 AM EST - 1 year ago

Esperion Announces $210 Million Convertible Debt Financing

ESPR


Esperion Therapeutics Earnings Call Transcript: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Esperion Therapeutics Earnings Call Transcript: Q3 2024


Esperion Therapeutics Quarterly report: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Esperion Therapeutics Quarterly report: Q3 2024


Esperion Therapeutics Earnings release: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Esperion Therapeutics Earnings release: Q3 2024


Esperion Therapeutics Slides: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Esperion Therapeutics Slides: Q3 2024


Esperion Therapeutics Earnings Call Transcript: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Esperion Therapeutics Earnings Call Transcript: Q2 2024


Esperion Therapeutics Quarterly report: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Esperion Therapeutics Quarterly report: Q2 2024


Esperion Therapeutics Earnings release: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Esperion Therapeutics Earnings release: Q2 2024


Esperion Therapeutics Slides: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Esperion Therapeutics Slides: Q2 2024


Esperion Therapeutics Slides: Corporate Presentation

Aug 8, 2024, 7:00 AM EDT - 2 years ago

Esperion Therapeutics Slides: Corporate Presentation


Enjoyycall
Enjoyycall Aug. 21 at 9:23 PM
$PSNL has already reached the same pre-close takeout-pump zone we saw in other M&A targets (including $ESPR in the 6–12 months before its deal). If I’m right, it drifts back down and settles in the 16.xx area (anchored to the $16.25 takeout). Should the close slip past January 1st, year-end emotions + tax-loss selling will add extra pressure — exactly the kind of setup they would aim for. Right now, it’s trading at roughly 1.15% of the take-out price, the same late-stage relationship we saw in ESPR (+CVR) and other M&A names just prior to closing
1 · Reply
maxhappy
maxhappy Aug. 21 at 5:12 PM
$ESPR Nobody asking for weekly scripts? I'm still here and I will forever think that Sheldung Koenig is one of the worst biotech CEOs of all time. He is a proud member:
0 · Reply
Enjoyycall
Enjoyycall Aug. 20 at 10:19 PM
$ESPR Knock knock DJ its coming....TDS will OWN YOU !
1 · Reply
__LucidDreamer__
__LucidDreamer__ Aug. 20 at 4:21 PM
$ESPR saw rumor that Sheldon allowed the execs at Daiichi and Otsuka to regularly fist him during late night "negotiations". Sheldon wasn't really open to it, until Ben explained that, since they were Asian, they had smaller hands. #probablytrue
1 · Reply
Enjoyycall
Enjoyycall Aug. 20 at 4:07 PM
$ESPRWe are squeezing the dog crap out of you fake bulls!!! Too bad most deleted and ran or blocked when ironically they cried about being blocked by others, we are still banking, the foot is and has been on! Furus all exposed, no inside info no nothing! The way it should be, skill only. Go mow the yard lol
0 · Reply
HowDidThatGetInThere
HowDidThatGetInThere Aug. 18 at 4:16 PM
$ESPR Wonder how much Sheldon made on this aquisition.
0 · Reply
Enjoyycall
Enjoyycall Aug. 18 at 2:19 PM
$ESPR GUTS lol still not there. Many thought they would, but almost all can't. Back to your cube lol
0 · Reply
Enjoyycall
Enjoyycall Aug. 18 at 12:24 AM
$ESPR Hows the cube working. Post more pictures...Why no derogatory words about the C suite. Come find me, I'll send the address
1 · Reply
Enjoyycall
Enjoyycall Aug. 12 at 5:52 AM
$ESPR Wonder what DJ looks like…will he be crying in the photo
1 · Reply
Enjoyycall
Enjoyycall Aug. 12 at 1:12 AM
$ESPR Even more accounts deleted. X accounts nuked too, some abandoned from our request. Run, but can’t hide
0 · Reply
Enjoyycall
Enjoyycall Aug. 11 at 1:11 PM
$ESPR This is how it’s done.
0 · Reply
Gregg617notEsprguy
Gregg617notEsprguy Aug. 10 at 10:26 PM
0 · Reply
OldManLogan
OldManLogan Aug. 9 at 1:00 AM
$ARDX If anyone wants to know what I mean by creating phantom premium, go look at the $ESPR chart... no one can do Phantom premium like Sheldon, but Raab has probably knocked us back enough that a $9 BO is going to feel glorious, even though the stock could be worth $15-20 in a year or two with proper opex management... stock is now ripe for an activist.
2 · Reply
Enjoyycall
Enjoyycall Aug. 7 at 8:38 PM
$ESPR 💪
0 · Reply
TheProgressiveGambit
TheProgressiveGambit Aug. 7 at 7:11 PM
$ESPR — Only on Stocktwits!
1 · Reply
Dave_100
Dave_100 Aug. 6 at 7:50 PM
$ESPR DS sales were flat last quarter too. Maybe I will chalk this one more up to a potential bullet dodged and less of a golden goose stolen out from under everyone. With some hindsight this is feeling more like a case of massive incompetence on the part of the C suite.
2 · Reply
Dave_100
Dave_100 Aug. 6 at 7:46 PM
$ESPR script growth still looks disappointing. So I guess they haven’t flipped the switch yet. Enbumyst is pathetic, still can barely crack 10 scripts per week. Not holding out much hope for the CVRs.
1 · Reply
Enjoyycall
Enjoyycall Aug. 3 at 11:37 PM
0 · Reply
josh23941
josh23941 Aug. 3 at 5:46 PM
0 · Reply
BillyBob1337
BillyBob1337 Jul. 31 at 9:41 PM
$ESPR $DENN same tactic with shorts...thoughts?
0 · Reply
Gregg617notEsprguy
Gregg617notEsprguy Jul. 29 at 3:50 PM
$ESPR posted this a few days ago my new play
2 · Reply
fortyeight
fortyeight Jul. 28 at 7:36 PM
$ESPR Because it has a corrupt BOD.
0 · Reply